• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

261
26
23
21
11

COUNTRY

7
5
4
4
3

CATEGORIES

  • 193
  • 91
  • 38
  • 19
  • 14
  • 9
  • 7
  • 6
  • 6
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

25
234
282
390

PUBLISHED

123
125
144
390

PRODUCT TYPE

208
182

Search "The Central Nervous Systems Market 2010 Report" returned 390 results.

PRODUCT TITLE

Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted

GBI Research, the leading business intelligence provider, has released its latest research “Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely...

November 2011
FROM
Other Central Nervous System Disorders - Pipeline Review, H2 2012 Other Central Nervous System Disorders - Pipeline Review, H2 2012 - Product Thumbnail Image

Other Central Nervous System Disorders - Pipeline Review, H2 2012

Other Central Nervous System Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Other Central Nervous System Disorders - Pipeline Review, H2 2012', provides an overview of the...

August 2012
FROM
Central Nervous System (CNS) Tumor - Pipeline Review, H2 2012 Central Nervous System (CNS) Tumor - Pipeline Review, H2 2012 - Product Thumbnail Image

Central Nervous System (CNS) Tumor - Pipeline Review, H2 2012

Central Nervous System (CNS) Tumor – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Central Nervous System (CNS) Tumor - Pipeline Review, H2 2012', provides an overview of the indication’s...

December 2012
FROM

Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011

Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011 Summary GlobalData's clinical trial report, “Other Central Nervous System Disorders Global Clinical Trials Review, Q1,...

February 2011
FROM

Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] Global Forecasts to 2017

A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems It traces its history to more than 2000 years ago,...

March 2013
FROM

Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010

Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 Summary GBI Research, the...

November 2011
FROM

Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) - Technology Trend Analysis – By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis – Estimates up to 2018

Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) - Technology Trend Analysis – By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape...

December 2013
FROM

The US Clinical Research Market Outlook to 2017 – Led by Aging Population and Rise of Chronic Diseases

The report titled ‘The US Clinical Research Market Outlook to 2017 – Led by Aging Population and Rise of Chronic Diseases' provides a comprehensive analysis of the various aspects such as market size,...

August 2013
FROM

Other Central Nervous System Disorders - Pipeline Review, H2 2013

Other Central Nervous System Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Other Central Nervous System Disorders - Pipeline Review, H2 2013', provides an overview of the...

October 2013
FROM

Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies

“Early Stage Drug Development in Disease Segments – Innovation Focuses on Stem Cell Therapies and Gene Therapies”, provides an in-depth analysis of the unmet needs, drivers and barriers that affect...

February 2011
FROM

Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment

GBI Research's new report “Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment” provides in-depth...

January 2013
FROM

Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies

This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection,...

February 2011
FROM

Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology

“Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology”, provides in-depth analysis of innovations in protein...

May 2011
FROM

Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia

“Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia” gives a robust idea about the patient recruitment status...

September 2011
FROM
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine - Product Thumbnail Image

Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine

This market trends report presents the results from our latest industry tracking completed in March 2010 The data presented herein are based on primary market surveys from a worldwide respondent pool...

April 2010

Pharmaceutical & Healthcare Annual Deals Analysis 2011

Pharmaceutical & Healthcare Annual Deals Analysis 2011 Summary GlobalData's “Pharmaceutical & Healthcare Annual Deals Analysis 2011” report is an essential source of data and trend analysis on partnerships,...

March 2011
FROM
Successful Strategies for Pharmaceutical Reformulation Successful Strategies for Pharmaceutical Reformulation - Product Thumbnail Image

Successful Strategies for Pharmaceutical Reformulation

This report assesses the various approaches to reformulation in the protection of revenues for pharmaceuticals that are in the midpoint of their lifecycles. Using case studies pulmonary, injectable,...

October 2011
FROM

Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions

“Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” provides key data, information and analysis of the...

December 2010
FROM

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

‘Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure’ provides insights into major drug failures during 2005–2010 The 20 drugs...

July 2011
FROM

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

GBI Research, the leading business intelligence provider, has released its latest research “Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology...

December 2011
FROM
Loading Indicator

Our Clients

Our clients' logos